Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-02-12 @ 3:06 PM
Study NCT ID:
NCT02393157
Status:
RECRUITING
Last Update Posted:
2025-08-08
First Post:
2015-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Sponsor:
Organization: